A prospective, single centre, open label, single arm pilot study to evaluate the efficacy and safety of Amlapitta Mishran Suspension in participants with endoscopic gastritis

BACKGROUND: Endoscopic gastritis is associated with symptoms of gastritis, along with endoscopic findings. Amlapitta Mishran has multiple active components that act via various mechanisms in patients with gastritis symptoms. We planned to conduct this study to find out the efficacy and safety of Aml...

Descripción completa

Detalles Bibliográficos
Autores principales: Shetty, Yashashri C., Koli, Paresh G., Lahoti, Manoj, Kulkarni, Savita, Rajput, Preeti, Chawda, Mukesh B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700308/
https://www.ncbi.nlm.nih.gov/pubmed/36436294
http://dx.doi.org/10.1016/j.jaim.2022.100664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700308/
https://www.ncbi.nlm.nih.gov/pubmed/36436294
http://dx.doi.org/10.1016/j.jaim.2022.100664

Ejemplares similares